What the studies show Semaglutide was originally developed and approved as a type 2 diabetes treatment, functioning as a GLP-1 (glucagon-like peptide-1) receptor agonist that stimulates insulin secretion, suppresses glucagon, and lowers blood sugar levels when used alongside diet and exercise
Its efficacy in promoting weight reduction, improving glycemic control, and potentially reducing cardiovascular risk factors positions it as a transformative option in obesity management
Achieving glowing, brighter skin requires consistency, patience, and a dedicated skincare routine
Hashimoto's thyroiditis and tirzepatide represent an important intersection of autoimmune thyroid disease and modern metabolic therapy
We integrate: Medical oversight Hormone-aware care Nutrition strategy Behavioral support Ongoing follow-up When you are ready, you can schedule a consultation directly to discuss a personalized plan that fits your goals and your physiology